forty-eight children and adolescents with severe primary obsessive-compulsive disorder completed a 10-week double-blind crossover trial of clomipramine hydrochloride ( mean dose [ +/- sd ] , 150 +/- 53 mg/d ) and desipramine hydrochloride ( mean dose [ +/- sd ] , 153 +/- 55 mg/d ) .
C0028768
obsessive-compulsive
C0282107
clomipramine